This inventor holds 7 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: Pharvaris Gmbh, Pharvaris Netherlands B.v., Shire Orphan Therapies Gmbh. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
3 out of 3 
1 out of 10 Years Active: 2013-2026
Title: Christoph Gibson: Innovator in Pharmaceutical Chemistry
Introduction
Christoph Gibson is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that act as bradykinin B2 receptor antagonists. With a total of 7 patents to his name, Gibson's work is focused on treating various skin diseases and other medical conditions.
Latest Patents
Gibson's latest patents include innovative compounds designed to act as bradykinin B2 receptor antagonists. One notable invention is a compound that serves as a bradykinin B2 receptor antagonist for treating skin diseases. This invention encompasses a pharmaceutical composition containing one or more of the compounds, as well as a combination preparation that includes at least one active pharmaceutical ingredient. The applications of this compound extend to treating a wide range of disorders, including skin disorders, eye diseases, gastrointestinal diseases, and even cancer.
Another significant patent involves 1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives. This compound also acts as a bradykinin B2 receptor antagonist and is intended for similar therapeutic uses as the previous invention.
Career Highlights
Throughout his career, Christoph Gibson has worked with notable companies in the pharmaceutical industry, including Pharvaris Netherlands B.V. and Pharvaris GmbH. His expertise in developing innovative pharmaceutical solutions has positioned him as a key figure in his field.
Collaborations
Gibson has collaborated with esteemed colleagues such as Joern Saupe and Horst-Dieter Ambrosi. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Christoph Gibson's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical treatments. His work continues to impact the field positively, addressing various health challenges with his groundbreaking inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile